F-Star Therapeutics Inc (FSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,684 | 4,347 | 1,570 | N/A | N/A |
| Marketable Securities | 14,046 | 5,335 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 11,562 | 0 | 0 |
| TOTAL | $25,570 | $9,995 | $13,679 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 522 | 427 | 126 | N/A | N/A |
| Investments And Advances | 752 | 3,189 | 0 | 0 | 0 |
| Other Non-Current Assets | 35 | 966 | 0 | 0 | 0 |
| TOTAL | $1,309 | $4,582 | $126 | $N/A | $N/A |
| Total Assets | $26,879 | $14,577 | $13,805 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,519 | 2,183 | 348 | 0 | 0 |
| Accrued Expenses | 1,982 | 1,363 | 1,257 | N/A | N/A |
| TOTAL | $3,501 | $3,546 | $1,605 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,360 | 6 | 0 | 0 | 0 |
| TOTAL | $6,360 | $6 | $N/A | $N/A | $N/A |
| Total Liabilities | $9,861 | $3,552 | $1,605 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,354 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 1 | N/A | N/A | N/A |
| Retained earnings | -51,535 | -34,169 | -22,605 | N/A | N/A |
| Other shareholders' equity | -7 | -18 | 0 | 0 | 0 |
| TOTAL | $17,018 | $11,025 | $12,200 | $N/A | $N/A |
| Total Liabilities And Equity | $26,879 | $14,577 | $13,805 | $0 | $0 |